Clinical Trial Update: Heme Arginate in Transplantation Study [Phase 3]

View source ↗

Summary

A Phase 3 study of Heme Arginate in renal transplantation (rejection and failure) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Failure
• Renal Transplant Rejection

Drugs mentioned

• Heme Arginate (heme arginate)

Snippet

Sponsor: University of Edinburgh | Conditions: Renal Transplant Rejection, Renal Transplant Failure | Phase 3 | Status: TERMINATED